🇺🇸 FDA
Patent

US 12329780

Acute and chronic mitochondrial electron transport chain dysfunction treatments and graphenic materials for use thereof

granted A61KA61K33/04A61K33/24

Quick answer

US patent 12329780 (Acute and chronic mitochondrial electron transport chain dysfunction treatments and graphenic materials for use thereof) held by The Board of Regents of the University of Texas System expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jun 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K33/04, A61K33/24, A61K33/241, A61K33/26